HOOKIPA Pharma Inc. HOOK
Set alert
1.15 USD 0.00 0.00%
As of Jul 17, 9:30 AM ET
1.15 Day range 1.15
52-week range unavailable
- YTD
- +28.78%
- 1 year
- -19.01%
- Open
- 1.15
- Prev close
- 1.15
- Mkt cap
- 14.40M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.15
- High
- 1.15
- Forward P/E
- -0.37
- Beta
- 0.83
- Short ratio
- 1.08
- Inst. own
- 37.16%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.09
- 200-d avg
- 5.66
- 1y target
- 23.50
Analyst view
Consensus: buy
Buy
Price target (mean) 23.50 +1943.5% upside
Now 1.15
- Target (low)
- 7.00
- Target (mean)
- 23.50
- Target (high)
- 40.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.97 | -0.97 – -0.97 | -2.20 | +55.9% | 6.25M | -15.6% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | 1.10 | 0.0% | 0 | 0.0% | 0 |
| Current year | -2.44 | -2.44 – -2.44 | -8.60 | +71.6% | 48.85M | +142.7% | 1 |
| Next year | -1.90 | -1.90 – -1.90 | -2.44 | +22.1% | 19.25M | -60.6% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Nov 21, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Nov 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 9, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jul 26, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jun 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 21, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Apr 26, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 25, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Mar 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 30, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 27, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Sep 6, 2023 | Truist Securities | Reiterated | Buy | Buy |
| Aug 11, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 30, 2023 | RBC Capital | Reiterated | Outperform | Outperform |
| Jun 5, 2023 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 20, 2023 | Truist Securities | Maintained | — | Buy |
| Mar 16, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Dec 2, 2022 | B of A Securities | Downgrade | Buy | Underperform |
| Nov 15, 2022 | RBC Capital | Maintained | — | Outperform |
| Aug 23, 2022 | Truist Securities | Maintained | — | Buy |
| Aug 11, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 25, 2022 | RBC Capital | Maintained | — | Outperform |
| Feb 17, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 16, 2022 | SVB Leerink | Maintained | — | Outperform |
| Nov 12, 2021 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 11, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 10, 2021 | SVB Leerink | Maintained | — | Outperform |
| Nov 10, 2021 | RBC Capital | Maintained | — | Outperform |